• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌完全治疗后的复发与死亡:泰国北部医院的经验

Recurrence and death from breast cancer after complete treatments: an experience from hospitals in Northern Thailand.

作者信息

Chairat Rungnapa, Puttisri Adisom, Pamarapa Asani, Wongrach Nongnoot, Tawichasri Chamaiporn, Patumanond Jayanton, Tantraworasin Apichat, Charoentum Chaiyut

出版信息

J Med Assoc Thai. 2014 Sep;97(9):932-8.

PMID:25536710
Abstract

OBJECTIVE

To describe the pattern of disease progression and to describe locoregional recurrence, distant recurrence, and death rates in breast cancer patients after complete treatment.

MATERIAL AND METHOD

Medical records of women diagnosed with breast cancer at two university affiliated tertiary care hospitals in the Northern Thailand that had complete treatments between 2006 and 2010 were traced. Extracted key information included patient clinical profiles and documented recurrence of cancer The causes of death were verified from breast cancer case registration database, death certificates through The Ministry of Internal Affairs'civil registration, by direct telephone contact, or by distributed prepaid postcards.

RESULTS

Medical records of 829 women diagnosed with breast cancer without prior evidence ofdistant metastasis, and had complete recommended treatment were included. Six hundred thirty seven women had not experienced any events up to the end of the follow-up (76.8%). The first occurring events were focused and categorized into three distinct types, locoregional recurrence (n = 83, median follow-up time = 34.2 months), distant recurrence (n = 78, median follow-up time = 35.4 months), and death without any evidences of locoregional or distant recurrences (n = 12, median follow-up time = 36.7 months). Distant recurrence after locoregional recurrence was reported (n = 33). There were 109 patient who had died (breast cancer related death) up to the end of the follow-up (13.2%). The three types of consecutively occurring deaths were death after locoregional recurrence without any distant recurrences (n = 15), death after distant recurrence with locoregional recurrence (n = 21), and death after documenited distant recurrence without any locoregional recurrences (n = 61).

CONCLUSION

The trend was that the rate of the first occurring locoregional recurrence was slightly higher than that of distant recurrence, The death rate in patients without any recurrences was much lower than in those experiencing prior recurrences. The rates of disease progression from local recurrence to distant recurrence and to death were approximately 5 to 7 times faster in patients who had experienced earlierprogressions.

摘要

目的

描述疾病进展模式,并描述乳腺癌患者在接受完整治疗后的局部区域复发、远处复发及死亡率。

材料与方法

追溯泰国北部两所大学附属三级护理医院2006年至2010年间确诊为乳腺癌且接受了完整治疗的女性患者的病历。提取的关键信息包括患者临床资料及记录的癌症复发情况。通过乳腺癌病例登记数据库、内政部民事登记处的死亡证明、直接电话联系或发放预付明信片等方式核实死亡原因。

结果

纳入829例诊断为乳腺癌且无远处转移先前证据并接受了完整推荐治疗的女性患者的病历。637例女性在随访结束时未发生任何事件(76.8%)。首次发生的事件集中并分为三种不同类型,即局部区域复发(n = 83,中位随访时间 = 34.2个月)、远处复发(n = 78,中位随访时间 = 35.4个月)以及无局部区域或远处复发证据的死亡(n = 12,中位随访时间 = 36.7个月)。报告了局部区域复发后的远处复发(n = 33)。随访结束时共有109例患者死亡(与乳腺癌相关的死亡)(13.2%)。连续发生的三种死亡类型分别为局部区域复发后无远处复发的死亡(n = 15)、远处复发伴局部区域复发后的死亡(n = 21)以及记录的远处复发后无局部区域复发的死亡(n = 61)。

结论

趋势是首次发生的局部区域复发率略高于远处复发率,无任何复发患者的死亡率远低于有先前复发患者的死亡率。在经历过早期进展的患者中,疾病从局部复发进展到远处复发再到死亡的速度大约快5至7倍。

相似文献

1
Recurrence and death from breast cancer after complete treatments: an experience from hospitals in Northern Thailand.乳腺癌完全治疗后的复发与死亡:泰国北部医院的经验
J Med Assoc Thai. 2014 Sep;97(9):932-8.
2
[Locoregional recurrences after conservative treatment of breast cancer stage I-II].[I-II期乳腺癌保守治疗后的局部区域复发]
Med Clin (Barc). 2002 Feb 16;118(5):161-5. doi: 10.1016/s0025-7753(02)72321-x.
3
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.立体定向消融放疗治疗早期非小细胞肺癌后疾病复发模式:一项回顾性分析。
Lancet Oncol. 2012 Aug;13(8):802-9. doi: 10.1016/S1470-2045(12)70242-5. Epub 2012 Jun 22.
4
Periodic follow-up after breast cancer and the effect on survival.乳腺癌后的定期随访及其对生存的影响。
Eur J Surg. 2001 Jul;167(7):490-6. doi: 10.1080/110241501316914849.
5
[Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].[晚期三阴性乳腺癌患者的治疗结果及临床病理特征]
Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):381-4.
6
Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.早期乳腺癌患者局部孤立性复发后死亡的预后因素
Cancer. 2002 Jun 1;94(11):2813-20. doi: 10.1002/cncr.10572.
7
Risk of Synchronous Distant Recurrence at Time of Locoregional Recurrence in Patients With Stage II and III Breast Cancer (AFT-01).Ⅱ期和Ⅲ期乳腺癌患者局部区域复发时远处同步复发的风险(AFT-01)
J Clin Oncol. 2018 Apr 1;36(10):975-980. doi: 10.1200/JCO.2017.75.5389. Epub 2018 Jan 31.
8
Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.新辅助化疗和手术之后,对临床II期和III期联合乳腺癌单独进行局部放疗。
Radiat Oncol. 2016 Jul 26;11:93. doi: 10.1186/s13014-016-0670-2.
9
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research.乳腺癌乳房切除术后首次孤立性局部区域复发:一项III期多中心研究结果,比较切除及放疗后全身治疗与观察。瑞士临床癌症研究组。
J Clin Oncol. 1994 Oct;12(10):2071-7. doi: 10.1200/JCO.1994.12.10.2071.
10
[Breast cancer relative survival after the first recurrence and related prognostic factors].[首次复发后乳腺癌的相对生存率及相关预后因素]
Med Clin (Barc). 2009 Oct 10;133(13):489-95. doi: 10.1016/j.medcli.2009.03.036. Epub 2009 Jul 25.

引用本文的文献

1
Follow-Up Strategies and Detection of Recurrent Breast Cancer in the Modern Era.现代时代下的复发性乳腺癌的随访策略与检测。
Asian Pac J Cancer Prev. 2023 Apr 1;24(4):1359-1366. doi: 10.31557/APJCP.2023.24.4.1359.
2
Triple-negative breast cancer suppressive activities, antioxidants and pharmacophore model of new acylated rhamnopyranoses from .三阴性乳腺癌抑制活性、抗氧化剂及来自……的新型酰化鼠李糖吡喃糖的药效团模型
RSC Adv. 2020 Mar 12;10(18):10584-10598. doi: 10.1039/d0ra01697g. eCollection 2020 Mar 11.
3
Individualized Prediction of Breast Cancer Survival Using Flexible Parametric Survival Modeling: Analysis of a Hospital-Based National Clinical Cancer Registry.
使用灵活参数生存模型对乳腺癌生存进行个体化预测:基于医院的国家临床癌症登记分析
Cancers (Basel). 2021 Mar 29;13(7):1567. doi: 10.3390/cancers13071567.
4
(-)-Oleocanthal Prevents Breast Cancer Locoregional Recurrence After Primary Tumor Surgical Excision and Neoadjuvant Targeted Therapy in Orthotopic Nude Mouse Models.(-)-油橄榄苦素可预防原位裸鼠模型中原发性肿瘤手术切除及新辅助靶向治疗后乳腺癌的局部复发。
Cancers (Basel). 2019 May 8;11(5):637. doi: 10.3390/cancers11050637.